90
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Presepsin level in predicting patients’ in-hospital mortality from sepsis under sepsis-3 criteria

, , , , , , & show all
Pages 733-739 | Published online: 13 Jun 2019

References

  • Prescott HC, Osterholzer JJ, Langa KM, et al. Late mortality after sepsis: propensity matched cohort study. Bmj. 2016;353:i2375. doi:10.1136/bmj.i299627189000
  • Emrath ET, Fortenberry JD, Travers C, et al. Resuscitation with balanced fluids is associated with improved survival in pediatric severe sepsis. Crit Care Med. 2017;45(7):1177. doi:10.1097/CCM.000000000000236528437373
  • Martin GS, Bassett P. Crystalloids vs. colloids for fluid resuscitation in the intensive care unit: a systematic review and meta-analysis. J Crit Care. 2018;50:144. doi:10.1016/j.jcrc.2018.11.03130540968
  • Tigabu BM, Davari M, Kebriaeezadeh A, et al. Fluid volume, fluid balance and patient outcome in severe sepsis and septic shock: a systematic review. J Crit Care. 2018;48:153. doi:10.1016/j.jcrc.2018.08.01830199843
  • Armstrong BA, Betzold RD, May AK. Sepsis and septic shock strategies. Surg Clin North Am. 2017;97(6):1339. doi:10.1016/j.suc.2017.07.00329132513
  • Harimtepathip P, Lee JR, Griffith E, et al. Quick sepsis-related organ failure assessment versus systemic inflammatory response syndrome criteria for predicting organ dysfunction and mortality. Cureus. 2018;10(10):e3511.30613455
  • Silosi CA, Silosi I, Padureanu V, et al. Sepsis and identification of reliable biomarkers for postoperative period prognosis. Rom J Morphol Embryol. 2018;59(1):77.29940615
  • Prescott HC, Angus DC. Enhancing recovery from sepsis: a review. Jama. 2018;319(1):62. doi:10.1001/jama.2017.1768729297082
  • Brodska H, Valenta J, Pelinkova K, et al. Diagnostic and prognostic value of presepsin vs. established biomarkers in critically ill patients with sepsis or systemic inflammatory response syndrome. Clin Chem Lab Med. 2018;56(4):658. doi:10.1515/cclm-2017-083929176018
  • Yaegashi Y, Shirakawa K, Sato N, et al. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother. 2005;11(5):234. doi:10.1007/s10156-005-0400-416258819
  • Mihajlovic D, Brkic S, Uvelin A, et al. Use of presepsin and procalcitonin for prediction of SeptiFast results in critically ill patients. J Crit Care. 2017;40:197. doi:10.1016/j.jcrc.2017.04.00828432884
  • de Guadiana Romualdo LG, Torrella PE, Acebes SR, et al. Diagnostic accuracy of presepsin (sCD14-ST) as a biomarker of infection and sepsis in the emergency department. Clin Chim Acta. 2017;464:6–11. doi:10.1016/j.cca.2016.11.00327823951
  • Wu CC, Lan HM, Han ST, et al. Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C-reactive protein: a systematic review and meta-analysis. Ann Intensive Care. 2017;7(1):91. doi:10.1186/s13613-017-0316-z28875483
  • Endo S, Suzuki Y, Takahashi G, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother. 2012;18(6):891. doi:10.1007/s10156-012-0435-222692596
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). Jama. 2016;315(8):801. doi:10.1001/jama.2016.028726903338
  • Yang HS, Hur M, Yi A, et al. Prognostic value of presepsin in adult patients with sepsis: systematic review and meta-analysis. PLoS One. 2018;13(1):e0191486. doi:10.1371/journal.pone.019148629364941
  • Kim H, Hur M, Moon HW, et al. Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis. Ann Intensive Care. 2017;7(1):27. doi:10.1186/s13613-017-0252-y28271449
  • Popa TO, Cimpoesu D, Dorobat CM. Diagnostic and prognostic value of presepsin in the emergency department. Rev Med Chir Soc Med Nat Iasi. 2015;119(1):69.25970945
  • Matera G, Quirino A, Peronace C, et al. Soluble CD14 subtype-a new biomarker in predicting the outcome of critically ill septic patients. Am J Med Sci. 2017;353(6):543–551. doi:10.1016/j.amjms.2017.03.03628641717
  • Sargentini V, Ceccarelli G, D’Alessandro M, et al. Presepsin as a potential marker for bacterial infection relapse in critical care patients. A preliminary study. Clin Chem Lab Med. 2015;53(4):567.24897401
  • Godnic M, Stubljar D, Skvarc M, et al. Diagnostic and prognostic value of sCD14-ST–presepsin for patients admitted to hospital intensive care unit (ICU). Wien Klin Wochenschr. 2015;127(13–14):521. doi:10.1007/s00508-015-0719-525854904